Recovery of Donor Hematopoiesis after Graft Failure and Second Hematopoietic Stem Cell Transplantation with Intraosseous Administration of Mesenchymal Stromal Cells

<div>Cumulative MSC production for 3 passages in patients after allogeneic hematopoietic stem cell transplantation. The data are presented as the mean ± standard error (M ± SE), donors—88 MSC samples; patients before allo-BMT (point 0)—44 samples; patients after 1st allo-BMT—35 samples; patients after 2nd allo-HSCT—5 samples for 30 days and 2 samples for 120 and 180 days.</div>

Stem Cells International

fig1

Figure 1

Figure 1: Recovery of Donor Hematopoiesis after Graft Failure and Second Hematopoietic Stem Cell Transplantation with Intraosseous Administration of Mesenchymal Stromal Cells 

Figure 1 | Recovery of Donor Hematopoiesis after Graft Failure and Second Hematopoietic Stem Cell Transplantation with Intraosseous Administration of Mesenchymal Stromal Cells 